[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Low Molecular Weight Heparin Market Report 2017

January 2018 | 102 pages | ID: UA0F46B1495EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Low Molecular Weight Heparin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Low Molecular Weight Heparin in these regions, from 2012 to 2022 (forecast).
United States Low Molecular Weight Heparin market competition by top manufacturers/players, with Low Molecular Weight Heparin sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Aspen
  • Sanofi-aventis
  • Pfizer
  • Opocrin
  • CSBIO
  • Dongying Tiandong Pharmaceutical
  • Changzhou Qianhong Bio-pharma
  • Techdow
  • Yantai Dongcheng Pharmaceutical Group
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Enoxaparin
  • Dalteparin
  • Tinzaparin
  • Fraxiparine
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Treatment of Venous Thromboembolism
  • Complications of Pregnancy
  • Cardioversion of Atrial Fibrillation/Flutter
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Low Molecular Weight Heparin Market Report 2017

1 LOW MOLECULAR WEIGHT HEPARIN OVERVIEW

1.1 Product Overview and Scope of Low Molecular Weight Heparin
1.2 Classification of Low Molecular Weight Heparin by Product Category
  1.2.1 United States Low Molecular Weight Heparin Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Low Molecular Weight Heparin Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Enoxaparin
  1.2.4 Dalteparin
  1.2.5 Tinzaparin
  1.2.6 Fraxiparine
1.3 United States Low Molecular Weight Heparin Market by Application/End Users
  1.3.1 United States Low Molecular Weight Heparin Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Treatment of Venous Thromboembolism
  1.3.3 Complications of Pregnancy
  1.3.4 Cardioversion of Atrial Fibrillation/Flutter
  1.3.5 Others
1.4 United States Low Molecular Weight Heparin Market by Region
  1.4.1 United States Low Molecular Weight Heparin Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Low Molecular Weight Heparin Status and Prospect (2012-2022)
  1.4.3 Southwest Low Molecular Weight Heparin Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Low Molecular Weight Heparin Status and Prospect (2012-2022)
  1.4.5 New England Low Molecular Weight Heparin Status and Prospect (2012-2022)
  1.4.6 The South Low Molecular Weight Heparin Status and Prospect (2012-2022)
  1.4.7 The Midwest Low Molecular Weight Heparin Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Low Molecular Weight Heparin (2012-2022)
  1.5.1 United States Low Molecular Weight Heparin Sales and Growth Rate (2012-2022)
  1.5.2 United States Low Molecular Weight Heparin Revenue and Growth Rate (2012-2022)

2 UNITED STATES LOW MOLECULAR WEIGHT HEPARIN MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Low Molecular Weight Heparin Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Low Molecular Weight Heparin Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Low Molecular Weight Heparin Average Price by Players/Suppliers (2012-2017)
2.4 United States Low Molecular Weight Heparin Market Competitive Situation and Trends
  2.4.1 United States Low Molecular Weight Heparin Market Concentration Rate
  2.4.2 United States Low Molecular Weight Heparin Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Low Molecular Weight Heparin Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES LOW MOLECULAR WEIGHT HEPARIN SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Low Molecular Weight Heparin Sales and Market Share by Region (2012-2017)
3.2 United States Low Molecular Weight Heparin Revenue and Market Share by Region (2012-2017)
3.3 United States Low Molecular Weight Heparin Price by Region (2012-2017)

4 UNITED STATES LOW MOLECULAR WEIGHT HEPARIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Low Molecular Weight Heparin Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Low Molecular Weight Heparin Revenue and Market Share by Type (2012-2017)
4.3 United States Low Molecular Weight Heparin Price by Type (2012-2017)
4.4 United States Low Molecular Weight Heparin Sales Growth Rate by Type (2012-2017)

5 UNITED STATES LOW MOLECULAR WEIGHT HEPARIN SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Low Molecular Weight Heparin Sales and Market Share by Application (2012-2017)
5.2 United States Low Molecular Weight Heparin Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES LOW MOLECULAR WEIGHT HEPARIN PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Aspen
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Low Molecular Weight Heparin Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Aspen Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Sanofi-aventis
  6.2.2 Low Molecular Weight Heparin Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sanofi-aventis Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.2 Low Molecular Weight Heparin Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pfizer Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Opocrin
  6.4.2 Low Molecular Weight Heparin Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Opocrin Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 CSBIO
  6.5.2 Low Molecular Weight Heparin Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 CSBIO Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Dongying Tiandong Pharmaceutical
  6.6.2 Low Molecular Weight Heparin Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Changzhou Qianhong Bio-pharma
  6.7.2 Low Molecular Weight Heparin Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Techdow
  6.8.2 Low Molecular Weight Heparin Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Techdow Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Yantai Dongcheng Pharmaceutical Group
  6.9.2 Low Molecular Weight Heparin Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 LOW MOLECULAR WEIGHT HEPARIN MANUFACTURING COST ANALYSIS

7.1 Low Molecular Weight Heparin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Low Molecular Weight Heparin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Low Molecular Weight Heparin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Low Molecular Weight Heparin Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES LOW MOLECULAR WEIGHT HEPARIN MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Low Molecular Weight Heparin Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Low Molecular Weight Heparin Sales Volume Forecast by Type (2017-2022)
11.3 United States Low Molecular Weight Heparin Sales Volume Forecast by Application (2017-2022)
11.4 United States Low Molecular Weight Heparin Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Low Molecular Weight Heparin
Figure United States Low Molecular Weight Heparin Market Size (K MT) by Type (2012-2022)
Figure United States Low Molecular Weight Heparin Sales Volume Market Share by Type (Product Category) in 2016
Figure Enoxaparin Product Picture
Figure Dalteparin Product Picture
Figure Tinzaparin Product Picture
Figure Fraxiparine Product Picture
Figure United States Low Molecular Weight Heparin Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Low Molecular Weight Heparin by Application in 2016
Figure Treatment of Venous Thromboembolism Examples
Table Key Downstream Customer in Treatment of Venous Thromboembolism
Figure Complications of Pregnancy Examples
Table Key Downstream Customer in Complications of Pregnancy
Figure Cardioversion of Atrial Fibrillation/Flutter Examples
Table Key Downstream Customer in Cardioversion of Atrial Fibrillation/Flutter
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Low Molecular Weight Heparin Market Size (Million USD) by Region (2012-2022)
Figure The West Low Molecular Weight Heparin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Low Molecular Weight Heparin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Low Molecular Weight Heparin Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Low Molecular Weight Heparin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Low Molecular Weight Heparin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Low Molecular Weight Heparin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Low Molecular Weight Heparin Sales (K MT) and Growth Rate (2012-2022)
Figure United States Low Molecular Weight Heparin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Low Molecular Weight Heparin Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Low Molecular Weight Heparin Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Low Molecular Weight Heparin Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Low Molecular Weight Heparin Sales Share by Players/Suppliers
Figure 2017 United States Low Molecular Weight Heparin Sales Share by Players/Suppliers
Figure United States Low Molecular Weight Heparin Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Low Molecular Weight Heparin Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Low Molecular Weight Heparin Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Low Molecular Weight Heparin Revenue Share by Players/Suppliers
Figure 2017 United States Low Molecular Weight Heparin Revenue Share by Players/Suppliers
Table United States Market Low Molecular Weight Heparin Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Low Molecular Weight Heparin Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Low Molecular Weight Heparin Market Share of Top 3 Players/Suppliers
Figure United States Low Molecular Weight Heparin Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Low Molecular Weight Heparin Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Low Molecular Weight Heparin Product Category
Table United States Low Molecular Weight Heparin Sales (K MT) by Region (2012-2017)
Table United States Low Molecular Weight Heparin Sales Share by Region (2012-2017)
Figure United States Low Molecular Weight Heparin Sales Share by Region (2012-2017)
Figure United States Low Molecular Weight Heparin Sales Market Share by Region in 2016
Table United States Low Molecular Weight Heparin Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Low Molecular Weight Heparin Revenue Share by Region (2012-2017)
Figure United States Low Molecular Weight Heparin Revenue Market Share by Region (2012-2017)
Figure United States Low Molecular Weight Heparin Revenue Market Share by Region in 2016
Table United States Low Molecular Weight Heparin Price (USD/MT) by Region (2012-2017)
Table United States Low Molecular Weight Heparin Sales (K MT) by Type (2012-2017)
Table United States Low Molecular Weight Heparin Sales Share by Type (2012-2017)
Figure United States Low Molecular Weight Heparin Sales Share by Type (2012-2017)
Figure United States Low Molecular Weight Heparin Sales Market Share by Type in 2016
Table United States Low Molecular Weight Heparin Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Low Molecular Weight Heparin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Low Molecular Weight Heparin by Type (2012-2017)
Figure Revenue Market Share of Low Molecular Weight Heparin by Type in 2016
Table United States Low Molecular Weight Heparin Price (USD/MT) by Types (2012-2017)
Figure United States Low Molecular Weight Heparin Sales Growth Rate by Type (2012-2017)
Table United States Low Molecular Weight Heparin Sales (K MT) by Application (2012-2017)
Table United States Low Molecular Weight Heparin Sales Market Share by Application (2012-2017)
Figure United States Low Molecular Weight Heparin Sales Market Share by Application (2012-2017)
Figure United States Low Molecular Weight Heparin Sales Market Share by Application in 2016
Table United States Low Molecular Weight Heparin Sales Growth Rate by Application (2012-2017)
Figure United States Low Molecular Weight Heparin Sales Growth Rate by Application (2012-2017)
Table Aspen Basic Information List
Table Aspen Low Molecular Weight Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Aspen Low Molecular Weight Heparin Sales Growth Rate (2012-2017)
Figure Aspen Low Molecular Weight Heparin Sales Market Share in United States (2012-2017)
Figure Aspen Low Molecular Weight Heparin Revenue Market Share in United States (2012-2017)
Table Sanofi-aventis Basic Information List
Table Sanofi-aventis Low Molecular Weight Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi-aventis Low Molecular Weight Heparin Sales Growth Rate (2012-2017)
Figure Sanofi-aventis Low Molecular Weight Heparin Sales Market Share in United States (2012-2017)
Figure Sanofi-aventis Low Molecular Weight Heparin Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Low Molecular Weight Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Low Molecular Weight Heparin Sales Growth Rate (2012-2017)
Figure Pfizer Low Molecular Weight Heparin Sales Market Share in United States (2012-2017)
Figure Pfizer Low Molecular Weight Heparin Revenue Market Share in United States (2012-2017)
Table Opocrin Basic Information List
Table Opocrin Low Molecular Weight Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Opocrin Low Molecular Weight Heparin Sales Growth Rate (2012-2017)
Figure Opocrin Low Molecular Weight Heparin Sales Market Share in United States (2012-2017)
Figure Opocrin Low Molecular Weight Heparin Revenue Market Share in United States (2012-2017)
Table CSBIO Basic Information List
Table CSBIO Low Molecular Weight Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure CSBIO Low Molecular Weight Heparin Sales Growth Rate (2012-2017)
Figure CSBIO Low Molecular Weight Heparin Sales Market Share in United States (2012-2017)
Figure CSBIO Low Molecular Weight Heparin Revenue Market Share in United States (2012-2017)
Table Dongying Tiandong Pharmaceutical Basic Information List
Table Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales Growth Rate (2012-2017)
Figure Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales Market Share in United States (2012-2017)
Figure Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Revenue Market Share in United States (2012-2017)
Table Changzhou Qianhong Bio-pharma Basic Information List
Table Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales Growth Rate (2012-2017)
Figure Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales Market Share in United States (2012-2017)
Figure Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Revenue Market Share in United States (2012-2017)
Table Techdow Basic Information List
Table Techdow Low Molecular Weight Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Techdow Low Molecular Weight Heparin Sales Growth Rate (2012-2017)
Figure Techdow Low Molecular Weight Heparin Sales Market Share in United States (2012-2017)
Figure Techdow Low Molecular Weight Heparin Revenue Market Share in United States (2012-2017)
Table Yantai Dongcheng Pharmaceutical Group Basic Information List
Table Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales Growth Rate (2012-2017)
Figure Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales Market Share in United States (2012-2017)
Figure Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Low Molecular Weight Heparin
Figure Manufacturing Process Analysis of Low Molecular Weight Heparin
Figure Low Molecular Weight Heparin Industrial Chain Analysis
Table Raw Materials Sources of Low Molecular Weight Heparin Major Players/Suppliers in 2016
Table Major Buyers of Low Molecular Weight Heparin
Table Distributors/Traders List
Figure United States Low Molecular Weight Heparin Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Low Molecular Weight Heparin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Low Molecular Weight Heparin Price (USD/MT) Trend Forecast (2017-2022)
Table United States Low Molecular Weight Heparin Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Low Molecular Weight Heparin Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Low Molecular Weight Heparin Sales Volume (K MT) Forecast by Type in 2022
Table United States Low Molecular Weight Heparin Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Low Molecular Weight Heparin Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Low Molecular Weight Heparin Sales Volume (K MT) Forecast by Application in 2022
Table United States Low Molecular Weight Heparin Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Low Molecular Weight Heparin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Low Molecular Weight Heparin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Low Molecular Weight Heparin Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications